Joana Goncalves

CIK: 0001756991

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)40 (62.5%)

Position reduction

Option Exercises (M)22 (34.4%)

Derivative conversions

Awards (A)2 (3.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ORKA

Oruka Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (64 total)

ORKA
Oruka Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
1.8K shares at avg. $74.69$138K
ORKA
Oruka Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
700 shares at avg. $76.67$54K
ORKA
Oruka Therapeutics, Inc.
Oct 15, 2026
Exercise(M)
Direct
3.5K shares at avg. $6.84$24K
ORKA
Oruka Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
1.4K shares at avg. $75.48$106K
ORKA
Oruka Therapeutics, Inc.
Oct 15, 2026
Exercise(M)
Direct
3.5K shares at avg. $7.80$27K
ORKA
Oruka Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
200 shares at avg. $77.71$16K
ORKA
Oruka Therapeutics, Inc.
Oct 15, 2026
Sale(S)
Direct
2.9K shares at avg. $73.89$211K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
3.2K shares at avg. $92.03$290K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
1.4K shares at avg. $92.99$127K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
2.4K shares at avg. $91.10$217K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Exercise(M)
Direct
3.5K shares at avg. $7.80$27K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
100 shares at avg. $94.22$9K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
947 shares at avg. $95.71$91K
ORKA
Oruka Therapeutics, Inc.
Sep 15, 2026
Exercise(M)
Direct
3.5K shares at avg. $6.84$24K
ORKA
Oruka Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Direct
3.5K shares at avg. $6.84$24K
ORKA
Oruka Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
3.3K shares at avg. $112.01$372K
ORKA
Oruka Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Direct
3.5K shares at avg. $7.80$27K
ORKA
Oruka Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
900 shares at avg. $109.65$99K
ORKA
Oruka Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
300 shares at avg. $110.52$33K
ORKA
Oruka Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Direct
2.5K shares at avg. $112.56$279K
ORKA
Oruka Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
3.8K shares at avg. $86.68$330K
ORKA
Oruka Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
300 shares at avg. $87.25$26K
ORKA
Oruka Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
2.5K shares at avg. $85.86$214K
ORKA
Oruka Therapeutics, Inc.
Jul 15, 2026
Exercise(M)
Direct
3.5K shares at avg. $6.84$24K
ORKA
Oruka Therapeutics, Inc.
Jul 15, 2026
Exercise(M)
Direct
3.5K shares at avg. $7.80$27K

		Type	Shares	Price		Ownership
Oct 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	1,847	$74.69	$137,957	Direct
Oct 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	700	$76.67	$53,666	Direct
Oct 15, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$6.84	$23,940	Direct
Oct 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	1,400	$75.48	$105,677	Direct
Oct 15, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$7.80	$27,300	Direct
Oct 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	200	$77.71	$15,542	Direct
Oct 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,853	$73.89	$210,806	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	3,150	$92.03	$289,890	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	1,366	$92.99	$127,023	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,384	$91.10	$217,173	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$7.80	$27,300	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	100	$94.22	$9,422	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	947	$95.71	$90,637	Direct
Sep 15, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$6.84	$23,940	Direct
Aug 17, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$6.84	$23,940	Direct
Aug 17, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	3,320	$112.01	$371,886	Direct
Aug 17, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$7.80	$27,300	Direct
Aug 17, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	900	$109.65	$98,687	Direct
Aug 17, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	300	$110.52	$33,155	Direct
Aug 17, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,480	$112.56	$279,154	Direct
Jul 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	3,803	$86.68	$329,630	Direct
Jul 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	300	$87.25	$26,176	Direct
Jul 15, 2026	ORKA Oruka Therapeutics, Inc.	Sale(S)	2,497	$85.86	$214,385	Direct
Jul 15, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$6.84	$23,940	Direct
Jul 15, 2026	ORKA Oruka Therapeutics, Inc.	Exercise(M)	3,500	$7.80	$27,300	Direct

1-25 of 64 transactions

About Goncalves Joana

Goncalves Joana (SEC CIK 0001756991) files insider reports with the SEC as Chief Medical Officer of Oruka Therapeutics, Inc. (ORKA).

Signal8 holds 14 ownership filings by Goncalves Joana (1 Form 3, 13 Form 4), filed between Sep 6, 2024 and Oct 15, 2026. Those filings report 64 transactions, from Jan 22, 2025 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Goncalves Joana's filings is in MENLO PARK, CA.

Recent filings by Goncalves Joana

Oct 15, 2026: Open-market sales of ORKA shares (2 lines, Form 4, code S).
Oct 15, 2026: Option exercise of ORKA shares (Form 4, code M).
Oct 15, 2026: Open-market sale of ORKA shares (Form 4, code S).
Oct 15, 2026: Option exercise of ORKA shares (Form 4, code M).
Oct 15, 2026: Open-market sales of ORKA shares (2 lines, Form 4, code S).

Other insiders filing for Oruka Therapeutics, Inc. (ORKA)

Klein Lawrence Otto, Chief Executive Officer
Quinlan Paul T, General Counsel
Agarwal Arjun, Senior Vice President, Finance
Sandler Laura Lee, Chief Operating Officer
Edwards Larry Todd, Chief Commercial Officer
Fairmount Funds Management LLC, Director

How to read Form 4 transaction codes